Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4500bc7f9251b4869af20965162f0f94 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-396 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
filingDate |
2007-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee4e14cfe887845385d51fc6c8c1db20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab5961e7e0e36ec3e70bd706f7f5611d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e6f4de83b0911191ad69c52a6db9589 |
publicationDate |
2011-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-PI0707563-A2 |
titleOfInvention |
bladder cancer treatment using eo9 and propylene glycol |
abstract |
TREATMENT OF BLADDER CANCER USING EO9 AND PROPYLENE GLYCOL. Various treatments for bladder cancer and methods are disclosed here. The present disclosure can take advantage of concentrations of propylene glycol and / or NAD (P) H: quinone oxidoreductase-1 (NQOl), cytochrome P450 oxidoreductase (P45 OR) and glucose transporter 1 (Glut 1) and protein expression in the human transitional bladder carcinoma cell to offer individually targeted bladder cancer treatments. |
priorityDate |
2006-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |